ADM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Archer-Daniels-Midland Co (ADM) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock has shown a moderate price increase recently, but technical indicators are neutral, insider selling is significantly high, and financial performance has declined YoY. While analysts have raised price targets, the ratings remain mixed, and there are no strong proprietary trading signals or influential buying activity to support an immediate buy decision.
The MACD histogram is negative (-0.612) and contracting, RSI is neutral at 39.285, and moving averages are converging. The stock is trading below the pivot level of 70.413, with key support at 67.634 and resistance at 73.192. These indicators suggest a neutral trend with no clear buy signal.
Biofuel policy developments could also support growth in Carbohydrate Nutrition.
Insiders are selling heavily, with a 403.38% increase in selling activity over the last month. Financial performance in Q4 2025 showed significant declines in revenue (-13.68% YoY), net income (-19.58% YoY), and EPS (-20.34% YoY). Additionally, there are ongoing investigations into potential breaches of fiduciary duties, which could impact investor confidence.
In Q4 2025, revenue dropped to $18.56 billion (-13.68% YoY), net income fell to $456 million (-19.58% YoY), and EPS decreased to 0.94 (-20.34% YoY). However, gross margin improved slightly to 6.54% (+3.48% YoY). Overall, the financial performance indicates a challenging environment.
Analyst ratings are mixed. Jefferies and Barclays raised price targets to $77, citing improved margins and biofuel policy support. However, JPMorgan maintains an Underweight rating, and BMO Capital remains cautious with a Market Perform rating. The consensus reflects uncertainty about the magnitude of future growth.
